Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Under Contract with U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu
AVI BioPharma, 06/23/09

AVI BioPharma, Inc. , a developer of RNA-based drugs, is under contract with the U.S. Defense Threat Reduction Agency for development of one or more nucleotide-based candidate drugs targeting the present epidemic of H1N1 swine flu.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi Pasteur and the Alliance for Rabies Control enter into a global partnership
Sanofi-aventis, 10/05/09

Sanofi-aventis to acquire Oenobiol, French leader in nutritional beauty supplements
Sanofi-aventis, 11/02/09

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
GlaxoSmithKline, 10/14/09

See All of M&A/Partnerships

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

See All of Research & Development